Purchases are not available yet. You can browse the site and sign in.
First Time Microdosing: What to Expect & How to Prepare · Microdosing College
Foundations
Your First Microdose: What to Expect and How to Prepare
By Microdosing College Editorial·Last updated September 25, 2026·8 min read
First time microdosing psilocybin is not like taking a supplement. The substance is pharmacologically active, the research is genuinely mixed, and what you notice — or don't notice — will be shaped as much by your mindset, setting, and expectations as by the molecule itself. This guide walks through preparation, the day itself, and what honest tracking looks like, framed as harm reduction rather than a promise of benefit.
The term microdose implies a dose too small to produce obvious perceptual effects — sub-perceptual by definition. In practice, individual sensitivity varies considerably. A survey of 1,116 microdosers (Hutten et al., 2019, ) found the most commonly reported side-effects were anxiety, impaired focus, and physiological discomfort — effects that are far more likely if a dose lands higher than intended.
International Journal of Neuropsychopharmacology
For psilocybin truffles (the form legally available in the Netherlands), a typical starting range cited in protocols is 0.5–1 g of fresh truffle. Many experienced practitioners recommend beginning at the lower end — or even below — of whatever range a protocol specifies. This is not timidity; it is information-gathering. Your first dose tells you how your body responds at that weight, on that day, with that batch. You can always increase on a future cycle; you cannot undo a dose that was too high.
Certain personal and medical factors make psilocybin microdosing genuinely risky rather than merely uncertain. A critical review of 57 human microdosing studies (Rieser et al., 2025, Current Opinion in Psychology) identified notable adverse effects and substantial individual variability in who responds and who does not — findings that underscore why pre-screening matters.
Do not proceed with your first microdose if any of the following apply:
Personal or family history of psychosis, schizophrenia, or bipolar I disorder. Serotonergic psychedelics can trigger or worsen psychotic symptoms. This is not a minor caveat.
Current use of lithium. The combination carries a documented risk of seizures.
Current use of SSRIs, MAOIs, or tramadol. Interactions are pharmacologically plausible and in some cases documented; discuss with a prescribing clinician before making any change.
Pregnancy or breastfeeding. Safety data does not exist.
Age under 18. The developing brain has different risk profiles.
An acutely stressful life period. Psychedelics tend to amplify emotional states, including difficult ones.
This list is not exhaustive. Use the self-screener and, where there is any clinical uncertainty, speak to a healthcare provider. The U.S. National Center for Complementary and Integrative Health (NCCIH) explicitly notes that psilocybin can cause serious adverse effects and that its safety in people with existing psychiatric conditions has not been established.
Choosing the right first day
The choice of when matters. On your first microdose day you have no personal data about how this substance affects you — so build in safety margins.
Choose a day with low external demands. Avoid your first dose before an important meeting, a driving commitment, childcare, or any situation where impairment — even mild and unexpected — would be harmful. A calm weekend morning or a slow weekday with flexible afternoon hours is more appropriate.
Do not combine with alcohol or cannabis on the same day. Interactions are unpredictable and complicate your ability to attribute what you feel to the psilocybin alone.
Arrange for a contact person. Tell someone you trust that you are experimenting, and agree on a way to reach them. This is not overreaction — it is responsible practice.
Set your context intentionally. Prepare a comfortable environment. Know in advance what you plan to do with the day: light work, a walk, journaling, something you can step away from easily. Some people find that anxiety about the dose itself is the main thing they notice; a calm, familiar setting reduces that considerably.
On what to concretely expect during the day itself — and how the experience compares to a full dose — our companion article what does a microdose feel like covers the phenomenology in detail.
What you may actually notice (and what you may not)
Honest expectation-setting is part of harm reduction. The controlled research is sobering. A comprehensive review of controlled microdosing trials (Marschall et al., 2024, Biological Psychiatry: CNNI) found that blinded, placebo-controlled studies produce far more modest effects than observational surveys — suggesting that expectation plays a substantial role in what people report feeling.
On your first microdose, at a low starting dose, most people notice:
Nothing dramatic — this is the intended outcome and a sign the dose is in the right range.
Mild heightening of sensory detail or a subtle shift in the quality of attention, occasionally.
Slight anxiety or restlessness in the first hour or two, particularly if you are anxious about the experience itself.
A vague sense of energy or openness that is difficult to distinguish from ordinary mood variation.
If you notice clear visual changes, strong emotional amplification, difficulty concentrating, or anything that feels like a "high," your dose was above the sub-perceptual threshold. Note it precisely in your journal and reduce the amount next time. Our guide on signs your microdose is too high walks through those signals in more detail.
The day after your first dose, some people report what researchers have termed an "afterglow" — a mild positive shift in mood or energy. A systematic review of post-dose subacute effects (Evens et al., 2023, Therapeutic Advances in Psychopharmacology) covering 48 studies and 1,774 participants found evidence for both beneficial subacute effects and mild adverse ones in the days following psychedelic administration. Whether you experience anything similar is individual and not guaranteed.
Tracking honestly: the journal is the protocol
Because the effects of microdosing are subtle and influenced by expectation, a structured journal is the only tool that lets you distinguish genuine signal from wishful thinking or nocebo effects.
For each dose day and each off-day, record at minimum:
Dose taken (weight in grams, batch or product, time of day)
Mood and energy (a simple 1–10 scale is sufficient)
Sleep the night before, and sleep the following night
Any notable thoughts, sensations, or difficulties
Anything else that happened that might explain mood variation (stressful news, exercise, caffeine, alcohol, poor sleep)
The last point is important. If you feel better on a dose day, that is genuinely useful information — but only if you can rule out that you slept better, exercised, or avoided the stressful meeting that dominated your previous week. Without those confounders recorded, the journal cannot do its job.
Review your journal after a full four-week cycle before deciding whether to continue, adjust, or stop. Our guide on microdosing expectations vs. reality discusses what people tend to find when they look at their actual notes versus what they anticipated.
If something goes wrong
If you feel unexpectedly distressed, confused, or overwhelmed — even on a low dose — stop what you are doing, move to a calm, safe space, and contact someone you trust. The experience will pass. Most adverse reactions to low-dose psilocybin resolve within a few hours as the substance clears.
Do not drive or operate machinery if you feel any impairment. If distress is severe, does not resolve, or involves suicidal thinking, contact emergency services or a crisis line immediately. Our crisis resources page lists options by country.
First time microdosing is an experiment with an incompletely understood substance. Approaching it with preparation, a low starting dose, honest tracking, and a clear exit strategy is not excessive caution — it is what responsible use looks like.
Frequently asked
How much should I take for my first microdose?+
Start at the low end of whatever range a protocol specifies — for psilocybin truffles this is often 0.5–1 g of fresh truffle. Starting low gives you information about your individual sensitivity without risking a dose that crosses the sub-perceptual threshold. You can always increase in a future cycle.
What should I avoid on my first microdose day?+
Avoid driving commitments, childcare, important meetings, alcohol, and cannabis. Choose a low-demand day in a calm, familiar environment, and tell a trusted contact what you are doing. Do not combine with lithium, MAOIs, or other serotonergic medications.
Will I definitely feel something on my first microdose?+
Not necessarily — and noticing nothing dramatic is the intended outcome at a true microdose level. Controlled trials reviewed by Marschall et al. (2024) found considerably smaller effects than observational surveys, suggesting expectation plays a large role in reported experience.
What are the signs my first microdose was too high?+
Clear visual changes, strong emotional amplification, difficulty concentrating, or anything resembling a 'high' indicate you have exceeded the sub-perceptual threshold. Record the dose precisely in your journal and reduce the amount on your next dose day.
Who should not microdose at all?+
People with a personal or family history of psychosis, schizophrenia, or bipolar disorder; those taking lithium, MAOIs, or certain SSRIs; people who are pregnant or breastfeeding; and anyone under 18. The NCCIH notes that psilocybin can cause serious adverse effects and safety in existing psychiatric conditions has not been established. Use the screener at /screener before proceeding.
This guide is general educational information about microdosing, not medical advice and not a recommendation to use any substance. It can't account for your personal health. If you take medication or live with a mental-health condition, speak with a qualified professional before making any decision.
